Key result
Complete resistance to HBB or guanidine in echovirus-9 is due to single but different point mutations in the non-structural protein 2C, which do not alter NTPase activity.
Resistance to picornavirus replication inhibitors HBB and guanidine in echovirus-9 is mediated by distinct point mutations in viral protein 2C, without altering NTPase activity.
Answers are grounded in this paper and cite their sources.
May inform resistance surveillance for picornavirus antivirals; leaves open clinical translation beyond echovirus-9 models.
HBB [2-(alpha-hydroxybenzyl)-benzimidazole] and guanidine are potent inhibitors of picornavirus replication. Among other evidence, limited cross-resistance and a synergistic effect of both inhibitors suggest similar but not identical mechanisms of antiviral action. Echovirus-9 variants resistant to each of these drugs were characterized and sequenced. Complete resistance to HBB or guanidine was shown to be due to single but different point mutations in the non-structural protein 2C. Protein 2C was expressed as GST fusion and His-tagged proteins for the wild-type and various mutants. Although three mutations were located in or near conserved NTP binding motifs, NTPase activity was not altered in the presence of HBB or guanidine.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2000) studied Echovirus-9 infection (in vitro). HBB and guanidine was evaluated on Viral resistance and NTPase activity. Complete resistance to HBB or guanidine in echovirus-9 is due to single but different point mutations in the non-structural protein 2C, which do not alter NTPase activity.
Synapse has enriched 10 related papers. Consider them for comparative context: